Pharmafile Logo
Pharmafocus logo
Advanced Search

reform

Showing 15 posts of 28 posts found.

NHS image

Government pledges ‘new era’ for NHS

March 11, 2015
Research and Development, Sales and Marketing NHS, Simon Stevens, five year, reform, reorganisation, vanguard

The government is investing £200 million to back healthcare professionals to implement their own ideas for improving patient care. The …

News
nhs_parliament_2_8

Cancer Drugs Fund ‘papering over the cracks of a bigger issue’

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, Kadcyla, NICE, breast cancer, reform

Breakthrough Breast Cancer has raised concerns to the government this week over the ever-increasing price of new oncology medicines. Over …

News

NICE and market access: time for reform?

August 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bristol-Myers Squibb, NICE, Yervoy, reform

Earlier in the year, at the ABPI’s annual conference, the UK pharma lobby group released a new report suggesting that …

Feature
nhs_parliament_2

NHS reform: did the government get it right?

January 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DH, Hunt, Lansley, NHS, atkins, reform, reforms

Some nine months after the coalition government’s controversial health reforms came in, have they been a success? And how are …

Feature
Prescribing image

Charge more for prescriptions in England, say Reform

November 19, 2013
Sales and Marketing GP, NHS, UK, doctors, prescriptions, reform

Increase prescriptions to £10 and charge the same amount to see a GP if you want to help the NHS …

News

Reports back doctor contract changes

December 18, 2012
Sales and Marketing BMA, DDRB, NHS, doctors, reform

The government looks to be heading towards a showdown with clinician groups over proposed changes to doctors’ contracts. It has …

News
ABPI image

Whitehead to GPs: don’t squeeze the drugs budget

August 7, 2012
Medical Communications, Sales and Marketing ABPI, CCGs, GPs, NHS, PCTs, reform

GPs should value the drug industry and not seek to squeeze the drugs bill as their predecessors have done, says …

News

Social care plan criticised

July 13, 2012
Sales and Marketing Kings Fund, NHS, king's fund, reform, social care

A leading health think-tank has criticised what it calls the ‘financial vacuum’ at the heart of the government’s plans for …

News
Obama

Obama’s generics plan criticised

February 15, 2011
Sales and Marketing FDA, Obama, PhRMA, generics, reform

US pharma says new plans to end ‘pay-for-delay’ generics deals and shave five years from biologics exclusivity will threaten innovation …

News

Doctors express serious doubts about health reforms

October 1, 2010
Sales and Marketing BMA, NHS, healthcare reform, reform

The government’s plans for radical reform of the NHS has come under attack from doctors’ association the BMA, which says …

News
We the people

Vote brings US health reform closer

November 10, 2009
Sales and Marketing Obama, US, US healthcare, reform

Momentus reform of America’s healthcare system is a step closer following the passing of a bill in the House of …

News

US health reform clears first hurdle

October 14, 2009
Sales and Marketing Obama, Senate, US, US healthcare, hc, reform

The US Senate has approved the bill to reform America’s health care system, raising hopes that it can become law …

News

Conservatives leading on ‘industrial policy’ say CBI

September 16, 2009
Research and Development ABPI, hc, reform

 A change of government would benefit UK pharma, according to the Confederation of British Industry, which says the industry might …

News

The Trillion Dollar Project: US healthcare reform begins

July 17, 2009
Sales and Marketing Obama, US, healthcare, reform

The battle to determine how the US healthcare system will be reformed is heating up, with dozens of interest groups …

Feature

Battle ahead for US industry over biologics patents

June 12, 2009
Research and Development, Sales and Marketing PhRMA, US, generics, industry, reform

Moves to make it easier for biosimilars to be approved in the US are gaining momentum.The pharma industry has conceded …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026